Efficacy and Safety of Vibegron Add-on Therapy in Men With Persistent Storage Symptoms After Receiving Alpha 1-Blocker or Phosphodiesterase 5 Inhibitor: A Preliminary Study-Reference-Cited by-同舟云学术

Efficacy and Safety of Vibegron Add-on Therapy in Men With Persistent Storage Symptoms After Receiving Alpha 1-Blocker or Phosphodiesterase 5 Inhibitor: A Preliminary Study

Published:2021-07 Issue: Volume:153 Page:256-263
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Ishikawa Keisuke,Tsujimura Akira,Miyoshi Miho,Miyoshi Yuto,Ogasa Taiki,Hiramatsu Ippei,Uesaka Yuka,Nozaki Taiji,Shirai Masato,Mitsuhashi Isao,Sugimura Sosuke,Mizuno Taiki,Noto Kensho,Shigeta Yasuhiro,Honda Shinichi,Iwata Shinji,Horie Shigeo

Publisher

Elsevier BV

Subject

Urology

Reference28 articles.

1. The development of human benign prostatic hyperplasia with age;Berry;J Urol,1984

2. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society;Abrams;Urology,2003

3. Overactive bladder significantly affects quality of life;Abrams;Am J Manag Care,2000

4. Survey of overactive bladder symptoms influencing bother before and after treatment with tamsulosin hydrochloride in Japanese patients with benign prostatic hyperplasia;Tsujimura;Urology,2011

5. Clinical guidelines for male lower urinary tract symptoms and benign prostatic hyperplasia;Homma;Int J Urol,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effects of Vibegron Add-on Therapy on Alpha 1-Blocker Therapy for Sexual Function and Overactive Bladder Symptoms in Benign Prostatic Hyperplasia: A Prospective, Open-Label Study;Journal of Clinical Medicine;2024-07-05

2. Novel pharmacotherapeutic avenues for bladder storage dysfunction in men;Expert Opinion on Pharmacotherapy;2024-03-23

3. Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders;Pharmacological Reviews;2023-03-14

4. Current pharmacotherapy of overactive bladder;International braz j urol;2021-12

5. Efficacy of vibegron in patients with overactive bladder: Multicenter prospective study of real‐world clinical practice in Japan, SCCOP study 19‐01;LUTS: Lower Urinary Tract Symptoms;2021-10-28